[Elsevier] Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

jlmarti0512 Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-08-10 05:41

Reward10points

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01055-3/abstractTalazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trialNeeraj Agarwal 1, Arun A Azad 2, Joan Carles 3, Andre P Fay 4, Nobuaki Matsubara 5, Daniel Heinrich 6, Cezary Szczylik 7, Ugo De Giorgi 8, Jae Young Joung 9, Peter C C Fong 10, Eric Voog 11, Robert J Jones 12, Neal D Shore 13, Curtis Dunshee 14, Stefanie Zschäbitz 15, Jan Oldenburg 16, Xun Lin 17, Cynthia G Healy 18, Nicola Di Santo 19, Fabian Zohren 20, Karim Fizazi 21

Affiliations expand

Reply

All Reply0 Show all posts

jlmarti0512 Lv.4

Senior Member

[Elsevier] Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial Copy